Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study von Sangro, B, Yau, T, Hsu, C, Kudo, M, Crocenzi, T.S, Choo, S.-P, Meyer, T, Welling, T.H, Yeo, W, Chopra, A, Baakili, A, dela Cruz, C, Lang, L, Neely, J, Melero, I, El-Khoueiry, A.B, Trojan, J

Volltext

P1318 : Phase I dose escalation study of the safety, immunoregulatory activity, pharmacokinetics, and preliminary antitumor activity of nivolumab in advanced hepatocellular carcino... von Sangro, B, El-Khoueiry, A.B, Crocenzi, T.S, Welling, T.H, Feely, W, Anderson, J.A, Cruz, C. dela, Melero, I

Volltext

GS-010 - Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study von Sangro, B., Yau, T., Hsu, C., Kudo, M., Crocenzi, T.S., Choo, S.-P., Meyer, T., Welling, T.H., Yeo, W., Chopra, A., Baakili, A., dela Cruz, C., Lang, L., Neely, J., Melero, I., El-Khoueiry, A.B., Trojan, J.

Volltext

Sugar transport by the bacterial phosphotransferase system. Structural and thermodynamic domains of enzyme I of Salmonella typhimurium von LICALSI, C, CROCENZI, T. S, FREIRE, E, ROSEMAN, S

Volltext